Clinical Trial Update: NS-PFA Catheter Ablation of Paroxysmal Atrial Fibrillation With the Pulse Biosciences CellFX System [NA]

View source ↗

Summary

Clinical trial update for NS-PFA catheter ablation of paroxysmal atrial fibrillation using the Pulse Biosciences CellFX System; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Pulse Biosciences CellFX System

Snippet

Sponsor: Pulse Biosciences, Inc. | Conditions: Atrial Fibrillation Paroxysmal, Cardiac Ablation | NA | Status: NOT_YET_RECRUITING